Literature DB >> 28841579

Oxygen beams for therapy: advanced biological treatment planning and experimental verification.

O Sokol1, E Scifoni, W Tinganelli, W Kraft-Weyrather, J Wiedemann, A Maier, D Boscolo, T Friedrich, S Brons, M Durante, M Krämer.   

Abstract

Nowadays there is a rising interest towards exploiting new therapeutical beams beyond carbon ions and protons. In particular, [Formula: see text]O ions are being widely discussed due to their increased LET distribution. In this contribution, we report on the first experimental verification of biologically optimized treatment plans, accounting for different biological effects, generated with the TRiP98 planning system with [Formula: see text]O beams, performed at HIT and GSI. This implies the measurements of 3D profiles of absorbed dose as well as several biological measurements. The latter includes the measurements of relative biological effectiveness along the range of linear energy transfer values from  ≈20 up to  ≈750 keV μ [Formula: see text], oxygen enhancement ratio values and the verification of the kill-painting approach, to overcome hypoxia, with a phantom imitating an unevenly oxygenated target. With the present implementation, our treatment planning system is able to perform a comparative analysis of different ions, according to any given condition of the target. For the particular cases of low target oxygenation, [Formula: see text]O ions demonstrate a higher peak-to-entrance dose ratio for the same cell killing in the target region compared to [Formula: see text]C ions. Based on this phenomenon, we performed a short computational analysis to reveal the potential range of treatment plans, where [Formula: see text]O can benefit over lighter modalities. It emerges that for more hypoxic target regions (partial oxygen pressure of  ≈0.15% or lower) and relatively low doses (≈4 Gy or lower) the choice of [Formula: see text]O over [Formula: see text]C or [Formula: see text]He may be justified.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28841579     DOI: 10.1088/1361-6560/aa88a0

Source DB:  PubMed          Journal:  Phys Med Biol        ISSN: 0031-9155            Impact factor:   3.609


  9 in total

Review 1.  Combining Heavy-Ion Therapy with Immunotherapy: An Update on Recent Developments.

Authors:  Alexander Helm; Daniel K Ebner; Walter Tinganelli; Palma Simoniello; Alessandra Bisio; Valentina Marchesano; Marco Durante; Shigeru Yamada; Takashi Shimokawa
Journal:  Int J Part Ther       Date:  2018-09-21

Review 2.  Particle therapy in the future of precision therapy.

Authors:  Lukas Schaub; Semi Ben Harrabi; Juergen Debus
Journal:  Br J Radiol       Date:  2020-08-14       Impact factor: 3.629

3.  Radioactive Beams for Image-Guided Particle Therapy: The BARB Experiment at GSI.

Authors:  Daria Boscolo; Daria Kostyleva; Mohammad Javad Safari; Vasiliki Anagnostatou; Juha Äystö; Soumya Bagchi; Tim Binder; Georgios Dedes; Peter Dendooven; Timo Dickel; Vasyl Drozd; Bernhard Franczack; Hans Geissel; Chiara Gianoli; Christian Graeff; Tuomas Grahn; Florian Greiner; Emma Haettner; Roghieh Haghani; Muhsin N Harakeh; Felix Horst; Christine Hornung; Jan-Paul Hucka; Nasser Kalantar-Nayestanaki; Erika Kazantseva; Birgit Kindler; Ronja Knöbel; Natalia Kuzminchuk-Feuerstein; Bettina Lommel; Ivan Mukha; Chiara Nociforo; Shunki Ishikawa; Giulio Lovatti; Munetaka Nitta; Ikechi Ozoemelam; Stephane Pietri; Wolfgang R Plaß; Andrej Prochazka; Sivaji Purushothaman; Claire-Anne Reidel; Heidi Roesch; Fabio Schirru; Christoph Schuy; Olga Sokol; Timo Steinsberger; Yoshiki K Tanaka; Isao Tanihata; Peter Thirolf; Walter Tinganelli; Bernd Voss; Uli Weber; Helmut Weick; John S Winfield; Martin Winkler; Jianwei Zhao; Christoph Scheidenberger; Katia Parodi; Marco Durante
Journal:  Front Oncol       Date:  2021-08-19       Impact factor: 5.738

4.  Physics and biomedical challenges of cancer therapy with accelerated heavy ions.

Authors:  Marco Durante; Jürgen Debus; Jay S Loeffler
Journal:  Nat Rev Phys       Date:  2021-09-17

Review 5.  Technology-driven research for radiotherapy innovation.

Authors:  Claudio Fiorino; Matthias Guckemberger; Marco Schwarz; Uulke A van der Heide; Ben Heijmen
Journal:  Mol Oncol       Date:  2020-03-19       Impact factor: 6.603

6.  Impact of Target Oxygenation on the Chemical Track Evolution of Ion and Electron Radiation.

Authors:  Daria Boscolo; Michael Krämer; Martina C Fuss; Marco Durante; Emanuele Scifoni
Journal:  Int J Mol Sci       Date:  2020-01-09       Impact factor: 5.923

Review 7.  Carbon Ion Radiobiology.

Authors:  Walter Tinganelli; Marco Durante
Journal:  Cancers (Basel)       Date:  2020-10-17       Impact factor: 6.575

8.  Including Volume Effects in Biological Treatment Plan Optimization for Carbon Ion Therapy: Generalized Equivalent Uniform Dose-Based Objective in TRiP98.

Authors:  Marco Battestini; Marco Schwarz; Michael Krämer; Emanuele Scifoni
Journal:  Front Oncol       Date:  2022-03-21       Impact factor: 6.244

9.  Optimization of treatment planning for hypoxic tumours and re-modulation of radiation intensity in heavy-ion radiotherapy.

Authors:  Ladan Rezaee
Journal:  Rep Pract Oncol Radiother       Date:  2019-12-17
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.